Rho-kinase inhibitors do not expand hematoma volume in acute experimental intracerebral hemorrhage Post date May 13, 2022 Tags hemorrhagic stroke, Rho-associated kinase ← Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical → Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy
Neurovascular Research UnitNeurovascular Research Unit